Drug Standards
- (2)
- (4)
- (1)
- (3)
- (3)
- (665)
- (3)
- (27)
- (1)
- (6)
- (27)
- (61)
- (24)
- (1)
- (2)
- (35)
- (367)
- (45)
- (1)
- (2)
- (1)
- (5)
- (5)
- (4)
- (2)
- (7)
- (1)
- (5)
- (4)
- (3)
- (3)
- (1)
- (3)
- (2)
- (2)
- (1)
- (2)
- (3)
- (4)
- (2)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (5)
- (1)
- (2)
- (4)
- (1)
- (1)
- (3)
- (5)
- (3)
- (1)
- (2)
- (1)
- (1)
- (1)
- (3)
- (1)
- (1)
- (3)
- (4)
- (2)
- (2)
- (1)
- (4)
- (4)
- (5)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (3)
- (4)
- (3)
- (1)
- (4)
- (1)
- (2)
- (1)
- (5)
- (2)
- (2)
- (1)
- (5)
- (7)
- (3)
- (1)
- (1)
- (1)
- (4)
- (1)
- (3)
- (1)
- (4)
- (1)
- (8)
- (2)
- (1)
- (5)
- (13)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (4)
- (1)
- (5)
- (1)
- (1)
- (2)
- (1)
- (6)
- (2)
- (1)
- (2)
- (2)
- (1)
- (3)
- (1)
- (2)
- (2)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (2)
- (3)
- (1)
- (1)
- (1)
- (2)
- (4)
- (3)
- (1)
- (1)
- (5)
- (3)
- (2)
- (5)
- (1)
- (3)
- (1)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (2)
- (4)
- (4)
- (1)
- (2)
- (2)
- (1)
- (2)
- (4)
- (5)
- (2)
- (1)
- (3)
- (2)
- (2)
- (11)
- (1)
- (2)
- (2)
- (2)
- (5)
- (5)
- (4)
- (2)
- (4)
- (2)
- (1)
- (2)
- (5)
- (2)
- (2)
- (1)
- (2)
- (3)
- (2)
- (2)
- (5)
- (3)
- (2)
- (2)
- (1)
- (4)
- (3)
- (1)
- (1)
- (2)
- (2)
- (3)
- (2)
- (2)
- (3)
- (2)
- (1)
- (1)
- (5)
- (1)
- (2)
- (5)
- (5)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (1)
- (7)
- (2)
- (2)
- (1)
- (3)
- (1)
- (3)
- (2)
- (5)
- (2)
- (2)
- (2)
- (2)
- (5)
- (2)
- (1)
- (6)
- (3)
- (2)
- (1)
- (5)
- (5)
- (2)
- (2)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (5)
- (1)
- (2)
- (4)
- (1)
- (3)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (1)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (5)
- (2)
- (2)
- (1)
- (1)
- (2)
- (8)
- (4)
- (14)
- (7)
- (8)
- (1)
- (3)
- (1)
- (6)
- (1)
- (1)
- (5)
- (2)
- (1)
- (1)
- (2)
- (20)
- (4)
- (5)
- (1)
- (3)
- (2)
- (1)
- (7)
- (8)
- (7)
- (2)
- (1)
- (2)
- (1)
- (3)
- (5)
- (5)
- (1)
- (3)
- (1)
- (3)
- (6)
- (3)
- (3)
- (1)
- (2)
- (26)
- (54)
- (5)
- (11)
- (4)
- (6)
- (6)
- (16)
- (1)
- (129)
- (3)
- (1)
- (2)
- (5)
- (4)
- (14)
- (38)
- (3)
- (13)
- (12)
- (7)
- (1)
- (6)
- (6)
- (6)
- (1)
- (1)
- (1)
- (1)
- (1)
- (12)
- (38)
- (5)
- (1)
- (2)
- (1)
- (1)
- (12)
- (2)
- (15)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
- (6)
- (15)
- (2)
- (1)
- (19)
- (3)
- (18)
- (1)
- (1)
- (1)
- (1)
- (2)
- (1)
- (29)
- (3)
- (2)
- (1)
- (2)
- (1)
- (1)
- (6)
- (1)
- (1)
- (1)
- (1)
- (44)
- (2)
- (27)
- (1)
- (73)
- (6)
- (73)
Filtered Search Results
Apexbio Technology LLC Cinobufagin, 20mg. Cas: 470-37-1 MFCD: MFCD00056825.
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Cinobufagin is a specific Na+/K+-ATPase inhibitor. About as active as ouabain. Other sizes are available. Please inqury us for quote.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Dofetilide Related Compound A United States Pharmacopeia (USP) Reference Standard | 176447-94-2 | 25MG
Dofetilide Related Compound A United States Pharmacopeia (USP) Reference Standard | Mol Wt: 427.54 | 176447-94-2 | 25MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Apexbio Technology LLC Cabozantinib malate (XL184), 5mg. Cas: 1140909-48-3 MFCD: MFCD20923480. MET andVEGF receptor2 inhibitor
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Cabozantinib malate is a potent inhibitor of MET andVEGF receptor2 with IC50 values of 1.3nM and 0.035nM. 1140909-48-3. MFCD20923480
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
AdipoGen Carboplatin, 41575-94-4, MFCD00070464, 25 mg
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
MF: C6H12N2O4Pt, MW: 371.3, ≥98%, Appearance: White to off-white powder. Potent platinum-based antineoplastic agent. Analog of cisplatin (Prod. No. AG-CR1-3590) with reduced nephrotoxicity and higher stability. Antitumor agent. Forms inter- and intrastrand DNA adducts/crosslinks, consequently blocking DNA replication and transcription and inducing cell death. Interferes with cell division by mitosis. The damaged DNA elicits DNA repair mechanisms, which in turn activate apoptosis when repair is impossible. Apoptosis inducer. Enhances radiation-induced single-strand DNA breakage.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Apexbio Technology LLC Broad spectrum HDAC inhibitor, inhibits HDAC1-11 404950-80-7. MFCD09833242
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Broad spectrum HDAC inhibitor, inhibits HDAC1-11 404950-80-7. MFCD09833242
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Rosuvastatin impurity G | 1242184-42-4 | MFCD28579810 | 0.004 mg
Rosuvastatin impurity G | Mol Wt: 481.54 | 1242184-42-4 | MFCD28579810 | 0.004 mg
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Polyglyceryl 3 dioleate United States Pharmacopeia (USP) Reference Standard | 9007-48-1 | 1G
Polyglyceryl 3 dioleate United States Pharmacopeia (USP) Reference Standard | 9007-48-1 | 1G
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
U.S. Pharmacopeia Metoprolol tartrate, 56392-17-7, MFCD00056257, 200 mg
Linear Formula: (C15H25NO3)2 · C4H6O6, Molecular Weight: 684.81, Synonym: (±)-Metoprolol (+)-tartrate salt, (±)1-(Isopropylamino)-3-[p-(β-methoxyethyl)phenoxy]-2-propanol (+)-tartrate salt, Lopressor.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Amitriptyline N-AY-D-glucu
A certified SOLUTIONon standard of Amitriptyline N-AY-D-glucuronide a metabolite of the tricyclic antidepressant amitriptyline. Sold under trade names such as Amitrip Elavil and Levate amitriptyline is prescribed to treat a number of mental disorders ranging from major depressive disorder and anxiety disorder to bipolar disorder. This SOLUTIONon-based Certified Reference Material is applicable for use in LC/MS or GC/MS testing applications in clinical toxicology forensic analysis workplace drug testing and pharmaceutical research.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Sigma Aldrich Fine Chemicals Biosciences Rufinamide Related Compound B United States Pharmacopeia (USP) Reference Standard | 217448-86-7 | 25MG
Rufinamide Related Compound B United States Pharmacopeia (USP) Reference Standard | Mol Wt: 253.2 | 217448-86-7 | 25MG
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Selleck Chemical LLC Osimertinib (AZD9291) 5mg 1421373-65-0
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibitor with IC50 of 12.92, 11.44 and 493.8 nM for Exon 19 deletion EGFR, L858R/T790M EGFR, and WT EGFR in LoVo cells, respectively. Phase 3. *For Research & Development use only. Product is not intended for drug, household, or human consumption.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
![Chemscene ChemScene | N-[6-Chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-Benzenesulfonamide | 25G | CS-M1819 | 0.98 | 150727-06-3| MFCD09751194 | 526.01](https://assets.fishersci.com/TFS-Assets/CCG/product-images/CS-M1819.jpg-250.jpg)
Chemscene ChemScene | N-[6-Chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-Benzenesulfonamide | 25G | CS-M1819 | 0.98 | 150727-06-3| MFCD09751194 | 526.01
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
ChemScene | N-[6-Chloro-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)-Benzenesulfonamide | 25G | CS-M1819 | 0.98 | 150727-06-3| MFCD09751194 | 526.01
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC Flumazenil | 78755-81-4 | 99.99% | C15H14FN3O3 | 100 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Flumazenil is a competitive GABAA receptor antagonist primarily used to treat benzodiazepine overdoses. It works by interacting with the central benzodiazepine receptor to reverse the effects of benzodiazepine agonists.
- Reverses sedation from benzodiazepine overdoses
- Competitive GABAA receptor antagonist
- Solid appearance
- Melting point 201-203°C
- Soluble in DMSO (20 mg/mL)
- Powder storage at -20°C for 3 years or 4°C for 2 years
- Solution storage at -80°C for 2 years or -20°C for 1 year
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
![eMolecules 19455-23-3 | Potassium pivalate | Synthonix - Stock | MFCD00671345 | 140.223 | C5H9KO2 | 95.000 | [K+].CC(C)(C)C([O-])=O | 25g | 448043524](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000169323.jpg-250.jpg)
eMolecules 19455-23-3 | Potassium pivalate | Synthonix - Stock | MFCD00671345 | 140.223 | C5H9KO2 | 95.000 | [K+].CC(C)(C)C([O-])=O | 25g | 448043524
Potassium pivalate | Synthonix - Stock | 19455-23-3 | MFCD00671345 | 140.223 | C5H9KO2 | 95.000 | [K+].CC(C)(C)C([O-])=O | 25g | 448043524
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
![Medchemexpress LLC 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt | 124750-99-8 | 100.0% | 461.00 | 50 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000386489-logo.png-250.jpg){kind=logo}
Medchemexpress LLC 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt | 124750-99-8 | 100.0% | 461.00 | 50 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Losartan potassium is an angiotensin II receptor type 1 (AT1) antagonist, competing with the binding of angiotensin II to AT1 with an IC50 of 20 nM. This product is for research use only.
- Angiotensin II receptor type 1 (AT1) antagonist
- IC50 of 20 nM
- Purity 99.98%
- Appearance: white to off-white solid
- Store at 4°C, sealed, away from moisture
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More